Skip to main content
    M

    Minerva Neurosciences Inc (NERV)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.16
    -0.04 (-1.82%)

    Market Cap: $114.62M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Minerva Neurosciences Inc (NERV) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Minerva Neurosciences (NERV) has a market cap of $114.62M and an enterprise value of $94.40M. Its share count is up 551.25% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 17.64% below the market cap, as cash exceeds debt.

    Market Cap$114.62M
    Enterprise Value$94.40M
    Latest price (Nov 17, 2026)$2.16

    Key Dates

    The next earnings report is expected on Mar 9, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 9, 2027 (expected)
    Last Earnings DateNov 6, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 5.78% in the quarter ended Sep 30, 2026 and grew 155.20% a year over 2 years.

    Shares Outstanding49.29M
    Shares Change (YoY)+551.25%
    Shares Change (QoQ)+5.78%
    Share Count Growth (2Y CAGR)+155.20%

    Price Statistics

    The stock is down 47.45% over 52 weeks and trades 26.03% below its 50-day average.

    Beta (1Y)1.70
    52-Week Change-47.45%
    1-Month Change-6.90%
    3-Month Change-54.91%
    6-Month Change-50.46%
    5-Year Change-79.29%
    10-Year Change-97.40%
    Total Return (1Y)-47.45%
    Total Return (3Y CAGR)-25.48%
    Total Return (5Y CAGR)-25.56%
    Return vs SPY (1Y)-61.33%
    Max Drawdown (1Y)-73.23%
    Max Drawdown (3Y)-89.25%
    Sharpe Ratio (1Y)-0.77
    Correlation with SPY (1Y)0.26
    50-Day Average$2.92
    200-Day Average$4.79
    52-Week Range$1.96 to $8.80
    RSI (14 Days)36.8
    Average Volume (20 Days)192.12K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 33.02x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio33.02x
    Quick Ratio33.02x
    Debt / Equity0.00x
    Interest Coverage1.04x

    Returns and Efficiency

    Return on Assets (ROA)-295.96%
    Return on Capital Employed (ROCE)-14.55%
    ROA (5Y Average)-94.27%
    ROIC (5Y Average)165.19%

    Scores

    NERV has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$1.36K
    Operating Income-$41.73M
    Pretax Income-$290.81M
    Net Income-$290.86M
    EBITDA-$14.87M
    EBIT-$13.93M
    Reported EPS (TTM)-$27.74

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$20.22M
    Total Debt$0
    Net Cash$20.22M
    Net Cash Per Share$0.41
    Working Capital$80.88M
    Shareholder Equity-$97.52M
    Tangible Book Value-$112.39M
    Total Assets$98.28M
    Total Liabilities$184.06M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$31.40M
    FCF Per Share-$0.66
    Depreciation and Amortization$935.93K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Dividends and Yields

    NERV does not pay a dividend.

    Buyback Yield5.21%
    Shareholder Yield5.21%

    Stock Splits

    The last split was a 1-for-8 reverse split on Jun 21, 2022.

    Last Split DateJun 21, 2022
    Split TypeReverse split
    Split Ratio1:8

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About NERV

    What is NERV's market cap?

    Minerva Neurosciences has a market cap of $114.62M. Its enterprise value, which adds debt and subtracts cash, is $94.40M.

    How many shares of NERV are outstanding?

    Minerva Neurosciences has 49.29M shares outstanding. The count is up 551.25% from a year earlier.

    Does NERV pay a dividend?

    No. Minerva Neurosciences does not pay a dividend.

    How much debt does NERV have?

    Minerva Neurosciences has $0 of total debt and $20.22M of cash and equivalents, a net cash position of $20.22M.